John S. McBride
2017
In 2017, John S. McBride earned a total compensation of $647.3K as Former Chief Operating Officer and Chief Financial Officer at Tokai Pharmaceuticals, a 59% increase compared to previous year.
Compensation breakdown
| Option Awards | $73,405 |
|---|---|
| Salary | $169,918 |
| Other | $403,955 |
| Total | $647,278 |
McBride received $404K in other compensation, accounting for 62% of the total pay in 2017.
McBride also received $73.4K in option awards and $169.9K in salary.
Rankings
In 2017, John S. McBride's compensation ranked 10,923rd out of 14,666 executives tracked by ExecPay. In other words, McBride earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,923 out of 14,666 | 26th |
Division Manufacturing | 4,263 out of 5,772 | 26th |
Major group Chemicals And Allied Products | 1,532 out of 2,075 | 26th |
Industry group Drugs | 1,255 out of 1,731 | 28th |
Industry Pharmaceutical Preparations | 977 out of 1,333 | 27th |
Source: SEC filing on April 30, 2018.
McBride's colleagues
We found five more compensation records of executives who worked with John S. McBride at Tokai Pharmaceuticals in 2017.
2017
Gregory Flesher
Tokai Pharmaceuticals
Chief Executive Officer
2017
Jodie Morrison
Tokai Pharmaceuticals
Chief Executive Officer
2017
Catherine Turkel
Tokai Pharmaceuticals
President
2017
Christine Ocampo
Tokai Pharmaceuticals
Chief Financial Officer
2017
Jon Kuwahara
Tokai Pharmaceuticals